Jul 17, 2018   SOURCE: PR NewsWire

Epiomic Epidemiology Report: Hidradenitis Suppurativa Forecast In 21 Major Markets 2018-2028

DUBLIN, July 17, 2018 /PRNewswire/ --

The "Epiomic Epidemiology Series: Hidradenitis Suppurativa Forecast In 21 Major Markets 2018-2028" report has been added to ResearchAndMarkets.com's offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Epiomic Epidemiology Forecast Report on Hidradenitis Suppurativa in 21 Major Markets

Hidradenitis suppurativa (HS) is a chronic multifactorial in?ammatory skin disease with a serious negative effect on patient quality of life. It presents with painful lesionsnodules, abscesses, sinus tracts, etc.affecting mainly axillae, perineal and perianal areas and buttocks, as well as infra- and intermammary areas. The alternative name of the disease is acne inversa, and it usually affects areas unaffected by acne vulgaris.

This report provides the current prevalent population for HS across 21 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Belgium, Denmark, Russia, Turkey, Japan, China, South Korea, Singapore, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort. In addition to the current prevalence, the report provides an overview of the risk factors, diagnosis and prognosis of the disease, along with specific variations by geography and ethnicity.

Providing a value-added level of insight from our analysis team, HS patients grouped by disease stages, grades, phenotypes, number and type of lesions, certain parameters, as well as signs and comorbidities have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities of HS include:

    --  Infections
    --  Lymphatic obstruction
    --  Contractures with reduced mobility
    --  Perianal and perirectal sinuses and fistulae
    --  Pyoderma gangrenosum
    --  Ulcerative colitis
    --  Crohn's disease
    --  Arthropathy
    --  Overweight/obesity
    --  Depression
    --  Squamous cell carcinoma

Reasons to buy

    --  Ability to quantify patient populations in global HS market to target
        the development of future products, pricing strategies and launch plans.
    --  Further insight into the prevalence of the subdivided types of HS and
        identification of patient segments with high potential.
    --  Delivery of more accurate information for clinical trials in study
        sizing and realistic patient recruitment for various countries.
    --  Better understanding of the impact of specific co-morbid conditions on
        the prevalent population of HS patients.
    --  Identification of HS patient sub-populations that require treatment.
    --  Better understanding of the specific markets that have the largest
        number of HS patients.

Key Topics Covered: 

    1. List Of Tables And Figures
    2. Introduction
    3. Cause Of The Disease
    4. Risk Factors & Prevention
    5. Diagnosis Of The Disease
    6. Variation By Geography/Ethnicity
    7. Disease Prognosis & Clinical Course
    8. Key Comorbid Conditions / Features Associated With The Disease
    9. Methodology For Quantification Of Patient Numbers
    10. Top-Line Prevalence For Hidradenitis Suppurativa
    11. Features Of Hidradenitis Suppurativa Patients
    12. Areas Affected By Hidradenitis Suppurativa
    13. Comorbidities Of Hidradenitis Suppurativa Patients
    14. Abbreviations Used In The Report
    15. Other Services & Solutions
    16. Reports & Publications
    17. Online Epidemiology Databases
    18. Online Pharmaceutical Pricing Database
    19. References
    20. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/tv9zck/epiomic?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/epiomic-epidemiology-report-hidradenitis-suppurativa-forecast-in-21-major-markets-2018-2028-300682261.html

SOURCE Research and Markets